OTC - ACTIVE INGREDIENT SECTION
Active Ingredient: Benzocaine 10% w/v
Active Ingredient: Benzocaine 10% w/v
Purpose: Topical Anesthetic
Uses: For temporary relief of pain and itching associated with minor burns, scrapes, and insect bites
Warnings:
For external use only
Do not use: In the eyes, on broken skin, deep puncture wounds. I f unusal redness, swelling, irritation, or other symptoms occur, consult a physician immediately.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away
Flammable. Keep away from fire or flame. Avoid contact with eyes. If this happens, rinse thoroughly with water.
Directions: Wipe injection site vigorously and discard
Inactive Ingredient:
Isopropyl Alcohol, Purified Water
| Class | Version | Type | Effective |
|---|---|---|---|
| BENZOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 73288-006 | 73288-006-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ISOPROPYL ALCOHOL | ND2M416302 | IACT |
| BENZOCAINE | U3RSY48JW5 | ACTIB |
| WATER | 059QF0KO0R | IACT |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 3 | 2024-11-29 | full-release | 2026-06-01 00:39:47 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sting Relief Prep Pad | BENZOCAINE | NINGBO TIANBO FIRST AID PRODUCT CO., LTD. | 9487d15d-9116-4ff8-a004-ba0835ea091e | 2026-05-31 | Warnings | 73288-006-01 73288-006 73288000601 531f7bca-26ec-94a4-e063-6294a90ae8f0 9487d15d-9116-4ff8-a004-ba0835ea091e |
Adverse event summaries are temporarily unavailable. Other product information remains available.